Clinical Characteristics of Small Intestinal Bacterial Overgrowth in Individuals with Abdominal Distention

NCT06285734 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 402

Last updated 2024-12-12

No results posted yet for this study

Summary

Abdominal distention represents a prevalent clinical manifestation characterized by an unclear etiology and pathogenesis. This symptomatology is frequently observed in various conditions, including small intestinal bacterial overgrowth (SIBO) and abnormal orocecal transit time (OCTT). The utilization of the breath test as a non-invasive diagnostic approach has become widespread in recent years for identifying SIBO and abnormalities in OCTT. In this study, the prevalence of SIBO and OCTT irregularities in individuals presenting with abdominal distention was ascertained through the implementation of the breath test. Furthermore, the correlation between abdominal distention and SIBO/OCTT was analysed to enhance the elucidation of the underlying etiology of abdominal distention. These findings aim to offer valuable insights for refining clinical comprehension and strategies related to the diagnosis and treatment of abdominal distention.

Conditions

  • Abdominal Distention

Interventions

DIAGNOSTIC_TEST

Breath test

The concentration of methane and hydrogen in the exhaled gas of patients with Abdominal distention is measured by a breath test to determine the presence of SIBO and abnormal OCTT.

Sponsors & Collaborators

  • Qilu Hospital of Shandong University (Qingdao)

    collaborator OTHER
  • Jinan Central Hospital

    collaborator OTHER
  • Zaozhuang Municipal Hospital

    collaborator OTHER
  • Weihai Municipal Hospital

    collaborator OTHER
  • Central Hospital of Zibo

    collaborator OTHER
  • Weifang People's Hospital

    collaborator OTHER
  • Dezhou Hospital Qilu Hospital of Shandong University

    collaborator OTHER
  • Binzhou Medical University

    collaborator OTHER
  • Qihe Xian Renmin Hospital

    collaborator UNKNOWN
  • Shandong University

    lead OTHER

Principal Investigators

  • Feixue Chen, MD · Qilu Hospital of Shandong University

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-01
Primary Completion
2025-08-01
Completion
2025-08-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06285734 on ClinicalTrials.gov